The global biliary tract cancers (btcs) treatment market share analysis is on an upward trajectory, expected to reach USD 824.9 million by 2035, growing at a CAGR of 8.3% from its 2025 valuation of USD 372.5 million. The market’s expansion is largely driven by advancements in immunotherapy, increasing BTC incidence, the rising adoption of precision …